Intercellular adhesion molecule-1 deficiency protects MRL/MpJ-Fas(lpr) mice from early lethality

Area of Science:

• Immunology
• Pathology
• Genetics

Background:

• MRL/MpJ-Fas(lpr) mice exhibit severe systemic autoimmune disease resembling human lupus.
• This disease involves glomerulonephritis and vasculitis, leading to rapid mortality.

Purpose of the Study:

• To investigate the role of intercellular adhesion molecule-1 (ICAM-1) in the tissue injury of MRL/MpJ-Fas(lpr) mice.
• To determine if ICAM-1 deficiency impacts disease severity and survival.

Main Methods:

• Generation of ICAM-1-deficient MRL/MpJ-Fas(lpr) mice (ICAM-1/Fas(lpr)).
• Comparison of survival rates and blood urea nitrogen levels between Fas(lpr) and ICAM-1/Fas(lpr) mice.
• Histological analysis of kidney, lung, skin, and salivary glands.

Main Results:

• ICAM-1 deficiency significantly improved survival in Fas(lpr) mice (47 weeks vs. 26 weeks).
• Delayed elevation of blood urea nitrogen levels observed in ICAM-1/Fas(lpr) mice.
• Reduced glomerular disease and vasculitis in multiple organs of ICAM-1/Fas(lpr) mice.

Conclusions:

• ICAM-1 plays a critical role in the pathogenesis of glomerular and vascular injury in this autoimmune disease model.
• Targeting ICAM-1 may be a therapeutic strategy for severe autoimmune conditions like lupus.